FDA Approved: VARITHENA — Supplemental Application (Biocompatibles, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Varithena (polidocanol) by Biocompatibles, Inc., signaling an update to its labeling or indication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Varicose Veins

Drugs mentioned

• Varithena (polidocanol injectable foam)

Snippet

SUPPL AP for VARITHENA (POLIDOCANOL)